GSK begins global PR review

Pharmaceutical company GlaxoSmithKline is conducting a global PR agency review across its pharmaceutical, biological, and consumer healthcare businesses, according to multiple sources familiar with the matter.

HONG KONG: Pharmaceutical company GlaxoSmithKline is conducting a global PR agency review across its pharmaceutical, biological, and consumer healthcare businesses, according to multiple sources familiar with the matter.

The company sent out an RFP in recent weeks with the goal of realigning its PR roster, according to sources.

Several PR shops are on GSK's roster, including Burson-Marsteller, GolinHarris, and Grey's PR arm.

“It is a part of our regular review, which includes PR agencies,” a spokesperson for GSK told Campaign Asia-Pacific, “We do make adjustments now and then but nothing has been confirmed.”

The review follows the completion of a pitch for GSK's global media planning and buying account. In September 2013, GSK consolidated its $1 billion global media business at Group M and Omnicom Media Group. Dentsu retained its media buying in Japan.

The move ended GSK's relationship with Publicis Groupe's Starcom and Dentsu's Carat.

In October 2013, the pharma giant, which reportedly works with more than 100 agencies on its digital account, launched a global digital pitch, intent on streamlining the business. The company invited both roster and non-roster firms to compete for the work.

This story originally appeared on the website of Campaign Asia-Pacific.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.